Clinuvel Pharmaceuticals Ltd (CUVL) › Operating IncomeClinuvel Pharmaceuticals Ltd (CUVL): Operating IncomeAnnual figures by period end, from SEC filings.$27.92MYear ended 2026-06-30$28.53M2024-06-30: $28.53M2025-06-30: $26.52M2026-06-30: $27.92M$27.92M2024-06-30 Operating Income (USD) 2026-06-30Period endedOperating IncomeChange YoYSource filing2026-06-30$27.92M+5.3%2026-10-30, From 2025-07-012025-06-30$26.52M-7.0%2026-10-30, From 2024-07-012024-06-30$28.53Mn/a2026-10-30, From 2023-07-01Other metrics: RevenueCost of RevenueGross ProfitR&D ExpenseNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)